West Pharmaceutical Services Inc Stock News

West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Quintin Lai - VP, IR Eric Green - President and CEO Bernard Birkett - CFO

West Pharmaceutical's (WST) first-quarter earnings reflect strength in the Proprietary Products segment and operating margin expansion.

West Pharmaceutical Services Inc (NYSE: WST) reported first-quarter FY22 sales growth of 7.4% year-on-year to $720 million, missing the consensus of $720.92 million. Proprietary products segment re

West Pharmaceutical (WST) delivered earnings and revenue surprises of 5.50% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

West Pharmaceutical Services is becoming a vital component of the healthcare industry. West has provided critical products and services required for COVID-19 vaccines. WST is a "Dividend Aristocrat" a

EXTON, Pa. , April 14, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will rel

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

These companies are the rare breed that perform well while letting you sleep well at night.

Despite the COVID-19 pandemic-induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain

When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. The post 7 Healthcare Stocks to Buy for the Long Term appeared first o

We believe that Catalent stock, a global solutions provider for drugs, biologics, gene therapies, and consumer healthcare products, currently is an attractive pick over West Pharmaceutical Services, b

EXTON, Pa., March 9, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will part

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

If history is any guide, there may be trouble ahead for shares … Full story available on Benzinga.com

Hyderabad: West Pharmaceutical Services, which operates in injectable drug administration segment, appointed Ravikrishna Chebolu as GM of its India operations. While Wests global headquarter is in Exton, Pennsylvania, United States, in India the company has its sales office in Hyderabad, servicing customers throughout India. With over 20 years of relevant commercial and general management experience []